Hikma Pharmaceuticals PLC (HKMPY)
50.90
-0.65
(-1.26%)
USD |
OTCM |
May 17, 16:00
Hikma Pharmaceuticals Price to Book Value: 2.569 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 2.569 |
| May 16, 2024 | 2.602 |
| May 15, 2024 | 2.602 |
| May 14, 2024 | 2.528 |
| May 13, 2024 | 2.528 |
| May 10, 2024 | 2.528 |
| May 09, 2024 | 2.473 |
| May 08, 2024 | 2.473 |
| May 07, 2024 | 2.473 |
| May 06, 2024 | 2.473 |
| May 03, 2024 | 2.474 |
| May 02, 2024 | 2.474 |
| May 01, 2024 | 2.330 |
| April 30, 2024 | 2.347 |
| April 29, 2024 | 2.347 |
| April 26, 2024 | 2.347 |
| April 25, 2024 | 2.347 |
| April 24, 2024 | 2.347 |
| April 23, 2024 | 2.347 |
| April 22, 2024 | 2.347 |
| April 19, 2024 | 2.347 |
| April 18, 2024 | 2.347 |
| April 17, 2024 | 2.347 |
| April 16, 2024 | 2.347 |
| April 15, 2024 | 2.347 |
| Date | Value |
|---|---|
| April 12, 2024 | 2.379 |
| April 11, 2024 | 2.379 |
| April 10, 2024 | 2.379 |
| April 09, 2024 | 2.379 |
| April 08, 2024 | 2.379 |
| April 05, 2024 | 2.379 |
| April 04, 2024 | 2.379 |
| April 03, 2024 | 2.469 |
| April 02, 2024 | 2.396 |
| April 01, 2024 | 2.396 |
| March 28, 2024 | 2.396 |
| March 27, 2024 | 2.396 |
| March 26, 2024 | 2.458 |
| March 25, 2024 | 2.458 |
| March 22, 2024 | 2.458 |
| March 21, 2024 | 2.458 |
| March 20, 2024 | 2.458 |
| March 19, 2024 | 2.458 |
| March 18, 2024 | 2.415 |
| March 15, 2024 | 2.415 |
| March 14, 2024 | 2.415 |
| March 13, 2024 | 2.455 |
| March 12, 2024 | 2.455 |
| March 11, 2024 | 2.423 |
| March 08, 2024 | 2.423 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.317
Minimum
Oct 21 2022
4.238
Maximum
Oct 09 2020
2.810
Average
2.710
Median
Price to Book Value Benchmarks
| Adaptimmune Therapeutics PLC | 11.64 |
| Biodexa Pharmaceuticals Plc | 0.8756 |
| Verona Pharma PLC | 4.685 |
| NuCana PLC | 0.398 |
| Autolus Therapeutics PLC | 10.47 |
Price to Book Value Related Metrics
| PE Ratio | 29.94 |
| PS Ratio | 1.968 |
| Price to Free Cash Flow | 10.62 |
| Price | 50.90 |
| Earnings Yield | 3.34% |
| Market Cap | 5.647B |
| Operating PE Ratio | 9.369 |
| Normalized PE Ratio | 15.66 |